Additionally, SIRPI relieves the hypoxia of tumor based on its excellent catalase‐like (CAT‐like) enzyme activity, enabling efficient ROS generation to trigger specific pyroptotic tumor cell death via the caspase‐3/GSDME pathway in tumor tissue. The gene discussed is GSDME; the disease is neoplasm.